Saturday 17 October 2026
Export BDX’s income statement to Excel — free account
Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
191.75
2.01
−1.04%
Follow BDX
Becton, Dickinson and Company (BDX) SEC filings, changes and red flags
Red flags
-
Officer departure
Becton, Dickinson and Company reported the departure of an officer or director
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Jun 30, 2026 |
P1I2: 7 added · 10 removed · 54 modified P2I1A: no material changes, the filing says |
||
| 8-K | Aug 6, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jul 19, 2026 | 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | Officer departure | |
| 8-K | May 29, 2026 | 7.01 Regulation FD disclosure | ||
| 8-K | May 20, 2026 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits | ||
| 8-K | May 11, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2026 | |||
| 8-K/A | Oct 9, 2025 | 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | May 7, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 28, 2026 | 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 6, 2026 | 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 2, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 25, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 10, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Dec 31, 2025 | |||
| 8-K | Feb 9, 2026 | 1.01 Entry into a material definitive agreement; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 9, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 30, 2026 | 3.02 Unregistered sales of equity securities; 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 5, 2026 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 27, 2026 | 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 30, 2025 | 5.04 Suspension of trading under employee benefit plans | ||
| 8-K/A | Nov 17, 2025 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 10-K | Sep 30, 2025 |
1: 7 added · 12 removed · 33 modified 1A: 18 added · 13 removed · 57 modified 7: 36 added · 38 removed · 85 modified |
||
| 8-K | Nov 17, 2025 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 6, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Oct 9, 2025 | 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Sep 16, 2025 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2025 | |||
| 10-K | Sep 30, 2024 |